结核分枝杆菌38kD-16kD融合蛋白克隆表达及血清学诊断价值

摘要/Abstract

摘要： 目的构建重组结核分枝杆菌38kD-16kD融合蛋白,评价其在结核病血清学诊断方面的价值。方法通过聚合酶链反应扩增获得16kD和38kD基因片段，分别连接到表达载体pET21a中，同时将2片段两次连接到表达载体pET21a中，形成38kD-16kD(3816),16kD, 38kD重组载体；经表达、纯化和复性后，通过Western blot分析，以酶联免疫吸附试验检测184例血清抗体，肺结核患者96例、非结核肺部疾病患者50例，正常对照38例。结果成功构建重组质粒pET21a-3816，表达蛋白经SDS-PAGE后显示相对分子质量约为65kD，重组蛋白经镍柱纯化后，纯度均达90%以上；经Western blotting证实重组蛋白能与结核病患者血清反应；重组蛋白3816血清检测，其敏感性为80.2%(77/96)，特异性为90.9%(80/88)。结论成功表达和纯化了3816融合蛋白，其对血清学检测证明重组融合蛋白有希望成为结核病血清学诊断的有效候选者之一。

关键词: 分枝杆菌，结核, 重组融合蛋白质类, 血清学试验

Abstract: ObjectiveTo clone, express and purify the recombinant fusion protein 38kD-16kD of Mycobacterium tuberculosis, and to evaluate its potential value in TB serodiagnosis. MethodsThe genes coding 16kD and 38kD proteins were amplified by polymerase chain reaction (PCR) from the genome of Mycobacterium tuberculosis H₃₇Rv,and then cloned into expression vector pET21a,respectively. The fusion proteins 38kD-16kD were expressed in E.coli BL21(DE3). It was purified by his-tag of the fusion protein and renaturated by semipermeable membrane. Recombinant protein was analyzed by Western-blot. The purified recombinant protein was used as antigens to screen the sera from the patients with pulmonary TB (n=96),as well as other pulmonary disease (n=50), and clinically healthy controls(n=38) by ELISA. ResultsThe recombinant plasmid pET21a-38kD-16kD was obtained. The relative molecular mass of the protein was about 65000 Da by SDS-PAGE analysis. Specific immunogenicity of the recombinant protein was confirmed by western blot analysis. The Results of ELISA showed that the sensitivity and specificity of 38kD-16kD antigen were 80.2%(77/96) and 90.9%(80/88),respectively. ConclusionThe recombinant fusion protein 38kD-16kD was successfully expressed and purified, and may be a potential candidate of serodiagnostic reagent.

Key words: Mycobacterium tuberculosis, recombinant fusion proteins, serologic tests

刘忠华,丁元生,毕爱笑,冯永红,金瑞良,杨华,秦莲花,胡忠义. 结核分枝杆菌38kD-16kD融合蛋白克隆表达及血清学诊断价值[J]. 中国防痨杂志, 2009, 31(10): 565-568.

Liu Zhonghua, Ding Yuansheng，Bi Aixiao，Feng Yonghong, Jin Ruiliang,Yang Hua, Qin Linhua，Hu Zhongyi. Expression and immunological characteristics of recombinant fusion protein 38kD-16kD of Mycobacterium tuberculosis[J]. Chinese Journal of Antituberculosis, 2009, 31(10): 565-568.

参考文献

[1] Bothamley GH,Rudd R,Festenstein F,Ivanyi J.Clinical value of the measurement of Mycobacterium tuberculosis speciglic antibody in pulmonary tuberculosis [J].Thorax 1992.47(4):270-275.

[2] Wilkins,E,G,L.The serodiagosis of tuberculosis. 1994.367-369.
[3] 毛启龙，冯修光，昌增益.结核杆菌小分子热休克蛋白Hsp16.3的高效自发再折叠和再组装[J].生物化学与生物物理进展，2002，29（1）：87-90.
[4] Hu YM, Butcher PD, Sole K, Mitchison DA, Coates ARM. Protein synthesis is shutdown in dormant mycobacterium tuberculosis and is reversed by oxygen or heat shock [J]. FEMS Microbiol Lett, 1998,158(1):139-145.
[5] Britton WJ,Palengira V.Improving vaccines against tuberculosis [J].Immunal Cell Biol,2003,81(1):34-45.
[6] Jackett PS, Bothamley GH, Batra HV, Mistry A,Young DB, Ivanyi J. Specificity of antibodies in pulmonary tuberculosis [J]. J Clin Mcrobiol，1998,26(11):2313-2318.
[7] Zengyi Chang, Primm TP, Jakana J,Lee IH,Seryshevai I,Hiram F,Chiu W,Gilbert HF, Quiocho FA. Mycobacterium tuberculosis 16-kDa antigen (Hsp16.3) function as an oligomeric structure in vitro to suppress thermal aggregation [J]. J Biol Chem,1996,271(12):7218-7223.
[8] Wilkinson RJ,Haslov K,Rappuoli R,Giovannoni F,Narayanan PR,Desai CR,Vordermeier HM,Pauten J,Pasvol G,Ivnyi J,Singh M.Evaluation of the recombinant 38-kilodalton antigen of mycobacterium tuberculosis of a potential immunodignostic reagent [J].J Clin Microbiol,1997,35(3):553-557.
[9] Day CH, McNeill PD, Hendrickson RC, Skeiky YAW, Sampaio DP, Badaro R, Lyashchenko KP,Reed SG. Use of Multiepitope Polyproteins in serodiagnosis of Active Tuberculosis [J]. Clin Diag Immun,2002,9(4):883-891.
[10] 张小刚，何秀云，熊志红，熊志红，李书琳，张永胜.重组结核分枝杆菌38000蛋白质抗原免疫学特性的研究[J].实用医学杂志，2002，18（1）：19-20.
[11] 陈效友，马玙，李传友，焦旺旺，昌增益.结核分枝杆菌Hsp16.3和38kD蛋白融合基因的克隆与表达[J].中国防痨杂志，2002，24:60-61.
[12] Raja A,Uma Devi KR,Ramalingam B,Brennan PJ.Immunoglobulin G,A,and M respenses in serum and circulating immune complexes elicited by the 16-kilodalton antigen of Mycobacterium tuberculosis [J]. Clin Diagn Lab Immunol,2002,9(2):308-312.

[1]	都伟欣, 韦芬, 卢锦标, 赵爱华, 蒲江, 王国治, 徐苗. 冻干重组结核杆菌融合蛋白(EC)原液效力评价用国家参考品的初步建立[J]. 中国防痨杂志, 2020, 42(8): 826-831.
[2]	宋怡蒙, 李远春, 贺文从, 何萍, 包晶晶, 刘春法, 刘东鑫, 王鑫洋, 赵雁林, 李燕明. 荧光PCR探针熔解曲线技术检测MTB耐药性的成本分析[J]. 中国防痨杂志, 2020, 42(7): 712-717.
[3]	张洁, 任怡宣, 潘丽萍, 张宗德. 全基因组测序在结核分枝杆菌研究中的应用[J]. 中国防痨杂志, 2020, 42(7): 737-740.
[4]	张兴,王凤鸣,吕旭峰,华天齐,张学军,蒋靖怡,丁陈丽,朱伟,夏国栋,吉俊敏,赵飞. HIV感染/AIDS者结核感染的影响因素分析[J]. 中国防痨杂志, 2020, 42(4): 360-365.
[5]	赵皎洁,付雷,王彬,张蕾,胡明豪,陆宇. 抗结核药物体外药代动力学/药效学研究模型的建立及应用[J]. 中国防痨杂志, 2020, 42(4): 372-379.
[6]	杨翰,杨静芬,伍浩,崔晓利,党丽云. 微孔板法在一线抗结核药物敏感性试验中的应用价值[J]. 中国防痨杂志, 2020, 42(4): 380-384.
[7]	孙锦霞,张晴雯,李银虹,姜昕. 杨梅素通过磷脂酰肌醇3-激酶/蛋白激酶B/哺乳动物雷帕霉素靶蛋白信号通路诱导MTB感染巨噬细胞发生自噬的研究[J]. 中国防痨杂志, 2020, 42(2): 101-107.
[8]	刘彬彬,龚道方,陈振华,郭婧玮,余艳艳,刘丰平,欧阳辉,谭云洪. 三种实验室诊断技术对结核分枝杆菌复合群检出率及检测费用的比较研究[J]. 中国防痨杂志, 2020, 42(2): 143-148.
[9]	宋艳华,高孟秋,李琦. 结核分枝杆菌对乙硫异烟胺/丙硫异烟胺耐药的机制及其增敏剂研究进展[J]. 中国防痨杂志, 2020, 42(2): 173-177.
[10]	蒋明霞, 晁秀珍, 王兆芬, 马斌忠, 马永成, 王蓉, 王朝才, 李尔琛, 魏於家, 李咏雪, 张琪. 青海省南部地区154株结核分枝杆菌临床分离株耐药性检测结果分析[J]. 中国防痨杂志, 2020, 42(12): 1289-1293.
[11]	杨翰, 李爱芳, 王佩, 党丽云. DNA实时荧光恒温扩增法在结核病临床检测中的应用价值[J]. 中国防痨杂志, 2020, 42(12): 1294-1298.
[12]	杨映晖, 伍定辉, 苏伟明, 董春萍, 姚向阳. 基因芯片法在结核分枝杆菌耐药基因快速诊断中的应用价值[J]. 中国防痨杂志, 2020, 42(11): 1191-1195.
[13]	李冰莹, 郑旭彬, 胡屹, 徐飚. 全基因组数据分析工具TB Profiler v2.8.0、Mykrobe v0.7.0和PhyResSE v1.0在耐药结核病检测中的价值[J]. 中国防痨杂志, 2020, 42(11): 1196-1202.
[14]	买买提艾力·艾合木提, 黄巧玲, 古尔色曼·阿布拉, 热纳提·艾来提. 新疆喀什地区1307例肺结核患者行利福平和异烟肼耐药性检测的结果分析[J]. 中国防痨杂志, 2020, 42(11): 1209-1213.
[15]	宋克玉, 张琴, 王雯菁, 时瑞, 吴旭平. 2017—2019年南京市1719株分枝杆菌耐药情况分析[J]. 中国防痨杂志, 2020, 42(11): 1214-1220.